AJANTPHARM Quarterly Results, Profit & Loss, Balance Sheet (AJANTPHARM)

AJANTPHARM quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • AJANTPHARM Financials
  • AJANTPHARM Shareholding Pattern
  • AJANTPHARM Earnings Documents
  • AJANTPHARM Announcements
  • AJANTPHARM Corporate Actions
  • AJANTPHARM Bulk, Block & Insider Deals
  • AJANTPHARM Delivery Data
  • AJANTPHARM Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Ajanta Pharma Ltd (AJANTPHARM) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Ajanta Pharma Ltd reported sales of ₹1,794 Cr, operating profit of ₹548 Cr (OPM 31%) and net profit of ₹388 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

AJANTPHARM quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales1,1461,1701,3031,3541,3751,4221,6261,794
Expenses8258739511,0269931,0881,2021,247
Operating Profit321297351328382333424548
OPM28%25%27%24%28%23%26%31%
Other Income3018265925617137
Interest86535232
Depreciation3640414344454448
Profit before tax307269331341359347447535
Tax24%16%23%24%24%23%25%27%
Net Profit233225255260274267334388
EPS in Rs18.6418.0320.4420.8321.9121.3526.7531.06
AJANTPHARM profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales3,3413,7434,2094,6485,4536,217
Expenses2,4082,9343,0373,3793,9534,530
Operating Profit9338081,1721,2691,5001,687
OPM28%22%28%27%28%27%
Other Income11274858567195
Interest1067211613
Depreciation125131135144173181
Profit before tax9097451,1141,1891,3781,688
Tax22%21%27%23%23%-
Net Profit7135888169201,0561,263
EPS in Rs55.6345.8963.773.6884.52101.07
Dividend Payout11%15%79%38%33%-
AJANTPHARM balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital2525-2525
Reserves3,5423,765-4,5024,833
Borrowings3547-260154
Other Liabilities9271,067-1,2501,413
Total Liabilities4,5304,904-6,0376,425
Fixed Assets1,4791,762-1,8671,926
CWIP256176-258327
Investments349464-588620
Other Assets2,4462,502-3,3243,552
Total Assets4,5304,904-6,0376,425
AJANTPHARM cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity5627927851,157529
Cash from Investing Activity-74-56065-377-429
Cash from Financing Activity-460-108-1,051-733-168
Net Cash Flow28124-20147-68
Free Cash Flow431618646840169
CFO/OP86%117%94%117%59%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit861179411759
AJANTPHARM ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days11110310893124
Inventory Days347283283308289
Days Payable143147159155168
Cash Conversion Cycle315240233246246
Working Capital Days1408311997111
ROCE29%23%32%32%35%
  • AJANTPHARM Shareholding Pattern
  • AJANTPHARM Earnings Concalls
  • AJANTPHARM Growth Catalysts
  • AJANTPHARM Corporate Actions
  • AJANTPHARM Announcements
  • AJANTPHARM Results & Documents
  • AJANTPHARM Bulk & Block Deals
  • AJANTPHARM Delivery Data